Latest News About Ramipril

Updated 2026-05-29 12:05

Here are the latest publicly available updates on ramipril I could verify recently:

What this means for you:

Would you like me to fetch the most current recall notices for your location and provider-usable guidance, or summarize the typical monitoring steps while on ramipril? I can also help you interpret any notices you’ve received.[4][9][8]

Sources

Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 5mg ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a class 2 medicines recall for ramipril 5mg capsules. Crescent Pharma Limited is recalling one batch of Ramipril 5 mg Capsules as a precautionary measure due to a potential error at the manufacturing site. Crescent Pharma Limited has received one complaint to date, where it has been identified that a pack of ramipril 5 mg Capsules (Batch Number GR164099) contains blister strips of Amlodipine 5 mg Tablets inside the...

www.rpharms.com

Patient safety alert: Ramipril 5mg Capsules recall | Latest News

One batch of Ramipril 5 mg Capsules is being recalled as a precaution. Batch number: GR164099 Expiry date: 10/2026 Some cartons may contain Amlodipine 5 mg Tablets instead of Ramipril capsules due to a packaging error. … This is a Class 2 medicines recall, which means the issue could cause temporary or medically reversible health problems. What we are doing: Hospital wards supplied with this batch have been contacted and asked to check their stock. Any affected packs have been quarantined and...

swlstg.nhs.uk

About ramipril

NHS medicines information on ramipril – what it's used for and key facts.

www.nhs.uk

Ramipril - StatPearls - NCBI Bookshelf - NIH

Ramipril is an angiotensin-converting enzyme (ACE) inhibitor used to treat hypertension and prevent heart failure progression in patients with a history of myocardial infarction. This medication is also indicated for reducing the risk of myocardial infarction, stroke, and mortality in patients older than 55 who are at high risk for atherosclerotic disease and severe adverse cardiac events. Ramipril suppresses angiotensin II synthesis, reducing sympathetic activity and sodium and water...

www.ncbi.nlm.nih.gov